From the gut to the brain: Journey and pathophysiological effects of the food-associated trichothecene mycotoxin deoxynivalenol

Toxins

Volumn 5, Issue 4, 2013, Pages 784-820

  Maresca, Marc ^a  

^a AIX MARSEILLE UNIVERSITÉ   (France)

Author keywords

Brain; Deoxynivalenol; Detoxification; Endocrine; Glial cells; Immune cells; Intestinal absorption; Intestine; Mycotoxin; Trichothecene

Indexed keywords

INTERLEUKIN 8; PEPTIDE YY; SODIUM GLUCOSE COTRANSPORTER 1; TRICHOTHECENE; VOMITOXIN; XENOBIOTIC AGENT;

BACTERIAL METABOLISM; BACTERIAL TRANSLOCATION; BACTERIUM TRANSFORMATION; BLOOD BRAIN BARRIER; CYTOKINE RELEASE; DETOXIFICATION; DRUG CYTOTOXICITY; ENTERITIS; FOOD CONTAMINATION; FUSARIUM; HUMAN; INTESTINE ABSORPTION; INTESTINE FLORA; INTESTINE INFECTION; INTESTINE MUCOSA PERMEABILITY; LYMPHOCYTE PROLIFERATION; MACROPHAGE ACTIVATION; MAXIMUM ALLOWABLE CONCENTRATION; NONHUMAN; PATHOPHYSIOLOGY; PHYSICAL CHEMISTRY; REVIEW; RIBOSOME; RISK ASSESSMENT; STACHYBOTRYS; TIGHT JUNCTION; TOXICOKINETICS; TOXIN STRUCTURE; TRANSCYTOSIS; URINARY EXCRETION;

ANIMALS; BIOTRANSFORMATION; BLOOD-BRAIN BARRIER; BRAIN; ENDOCRINE SYSTEM; FOOD CONTAMINATION; FOODBORNE DISEASES; GASTROINTESTINAL TRACT; HUMANS; IMMUNE SYSTEM; INTESTINAL ABSORPTION; NEURONS; RISK ASSESSMENT; TRICHOTHECENES;

EID: 84877262122     PISSN: 20726651     EISSN: None     Source Type: Journal    
DOI: 10.3390/toxins5040784     Document Type: Review

References (172)

1. Pitt, J.I. Toxigenic fungi: Which are important? Med. Mycol. 2000, 38, 17-22.
2. Ueno, Y.; Nakajima, M.; Sakai, K.; Ishii, K.; Sato, N. Comparative toxicology of trichothec mycotoxins: Inhibition of protein synthesis in animal cells. J. Biochem. 1973, 74, 285-296.
3. Cundliffe, E.; Cannon, M.; Davies, J. Mechanism of inhibition of eukaryotic protein synthesis by trichothecene fungal toxins. Proc. Natl. Acad. Sci. USA 1974, 71, 30-34.
4. Rotter, B.A.; Prelusky, D.B.; Pestka, J.J. Toxicology of deoxynivalenol (vomitoxin). J. Toxicol. Environ. Health 1996, 48, 1-34.
5. Pestka, J.J.; Zhou, H.R.; Moon, Y.; Chung, Y.J. Cellular and molecular mechanisms for immune modulation by deoxynivalenol and other trichothecenes: Unraveling a paradox. Toxicol. Lett. 2004, 153, 61-73.
6. Pestka, J.J. Mechanisms of deoxynivalenol-induced gene expression and apoptosis. Food Addit. Contam. Part A 2008, 25, 1128-1140.
7. Pestka, J.J. Deoxynivalenol: Mechanisms of action, human exposure, and toxicological relevance. Arch. Toxicol. 2010, 84, 663-679.
8. Pestka, J.J. Deoxynivalenol-induced proinflammatory gene expression: Mechanisms and pathological sequelae. Toxins 2010, 2, 1300-1317.
9. Streit, E.; Schatzmayr, G.; Tassis, P.; Tzika, E.; Marin, D.; Taranu, I.; Tabuc, C.; Nicolau, A.; Aprodu, I.; Puel, O.; et al. Current situation of mycotoxin contamination and co-occurrence in animal feed-Focus on Europe. Toxins 2012, 4, 788-809.
10. Canady, R.; Coker, R.; Rgan, S.; Krska, R.; Kuiper-Goodman, T.; Olsen, M. Deoxynivalenol safety evaluation of certain mycotoxins in food. WHO Food Addit. Ser. 2001, 47, 420-555.
11. Schothorst, R.C.; van Egmond, H.P. Report from SCOOP task 3.2.10 "collection of occurrence data of Fusarium toxins in food and assessment of dietary intake by the population of EU member states"-Subtask: Trichothecenes. Toxicol. Lett. 2004, 153, 133-143.
12. Monbaliu, S.; van Poucke, C.; Detavernier, C.; Dumoulin, F.; van de Velde, M.; Schoeters, E.; van Dyck, S.; Averkieva, O.; van Peteghem, C.; de Saeger, S. Occurrence of mycotoxins in feed as analyzed by a multi-mycotoxin LC-MS/MS Method. J. Agric. Food Chem. 2010, 58, 66-71.
13. Pestka, J.J.; Smolinski, A.T. Deoxynivalenol: Toxicology and potential effects on humans. J. Toxicol. Environ. Health B 2005, 8, 39-69.
14. Maresca, M.; Fantini, J. Some food-associated mycotoxins as potential risk factors in humans predisposed to chronic intestinal inflammatory diseases. Toxicon 2010, 56, 282-294.
15. Sobrova, P.; Adam, V.; Vasatkova, A.; Beklova, M.; Zeman, L.; Kizek, R. Deoxynivalenol and its toxicity. Interdiscip. Toxicol. 2010, 3, 94-99.
16. Pinton, P.; Guzylack-Piriou, L.; Kolf-Clauw, M.; Oswald, I.P. The effect on the intestine of some fungal toxins: The trichothecenes. Curr. Immunol. Rev. 2012, 8, 193-208.
17. Bryden, W.L. Mycotoxins in the food chain: Human health implications. Asia Pac. J. Clin. Nutr. 2007, 16, 95-101.
18. Karlovsky, P. Biological detoxification of the mycotoxin deoxynivalenol and its use in genetically engineered crops and feed additives. Appl. Microbiol. Biotechnol. 2011, 91, 491-504.
19. Berthiller, F.; Crews, C.; Dall'Asta, C.; de Saeger, S.; Haesaert, G.; Karlovsky, P.; Oswald, I.P.; Seefelder, W.; Speijers, G.; Stroka, J. Masked mycotoxins: A review. Mol. Nutr. Food Res. 2013, 57, 165-186.
20. Sergent, T.; Parys, M.; Garsou, S.; Pussemier, L.; Schneider, Y.J.; Larondelle, Y. Deoxynivalenol transport across human intestinal Caco-2 cells and its effects on cellular metabolism at realistic intestinal concentrations. Toxicol. Lett. 2006, 164, 167-176.
21. Videmann, B.; Tep, J.; Cavret, S.; Lecoeur, S. Epithelial transport of deoxynivalenol: Involvement of human P-glycoprotein (ABCB1) and multidrug resistance-associated protein 2 (ABCC2). Food Chem. Toxicol. 2007, 45, 1938-1947.
22. Riley, R.J.; Martin, I.J.; Cooper, A.E. The influence of DMPK as an integrated partner in modern drug discovery. Curr. Drug Metab. 2002, 3, 527-550.
23. Vêtvicka, V.; Fornůsek, L. Limitations of transmembrane transport in drug delivery. Crit. Rev. Ther. Drug Carrier Syst. 1988, 5, 141-170.
24. Dobson, P.D.; Lanthaler, K.; Oliver, S.G.; Kell, D.B. Implications of the dominant role of transporters in drug uptake by cells. Curr. Top. Med. Chem. 2009, 9, 163-181.
25. Chow, J.; Lee, S.M.; Shen, Y.; Khosravi, A.; Mazmanian, S.K. Host-bacterial symbiosis in health and disease. Adv. Immunol. 2010, 107, 243-274.
26. Barnett, A.M.; Roy, N.C.; McNabb, W.C.; Cookson, A.L. The interactions between endogenous bacteria, dietary components and the mucus layer of the large bowel. Food Funct. 2012, 3, 690-699.
27. Walter, J.; Ley, R. The human gut microbiome: Ecology and recent evolutionary changes. Annu. Rev. Microbiol. 2011, 65, 411-429.
28. Frey, J.C.; Pell, A.N.; Berthiaume, R.; Lapierre, H.; Lee, S.; Ha, J.K.; Mendell, J.E.; Angert, E.R. Comparative studies of microbial populations in the rumen, duodenum, ileum and faeces of lactating dairy cows. J. Appl. Microbiol. 2010, 108, 1982-1993.
29. Smith, H.W. Observations on the flora of the alimentary tract of animals and factors affecting its composition. J. Pathol. Bacteriol. 1965, 89, 95-122.
30. Farner, D.S. The hydrogen ion concentration in avian digestive tracts. Poultr. Sci. 1942, 21, 445-450.
31. Ao, T.; Cantor, A.H.; Pescatore, A.J.; Pierce, J.L. In vitro evaluation of feed-grade enzyme activity at pH levels simulating various parts of the avian digestive tract. Anim. Feed Sci. Technol. 2008, 140, 462-468.
32. Goyarts, T.; Dänicke, S. Bioavailability of the Fusarium toxin deoxynivalenol (DON) from naturally contaminated wheat for the pig. Toxicol. Lett. 2006, 163, 171-182.
33. Prelusky, D.B.; Hartin, K.E.; Trenholm, H.L.; Miller, J.D. Pharmacokinetic fate of 14C-labeled deoxynivalenol in swine. Fundam. Appl. Toxicol. 1988, 10, 276-286.
34. Dänicke, S.; Valenta, H.; Döll, S. On the toxicokinetics and the metabolism of deoxynivalenol (DON) in the pig. Arch. Anim. Nutr. 2004, 58, 169-180.
35. Avantaggiato, G.; Havenaar, R.; Visconti, A. Evaluation of the intestinal absorption of deoxynivalenol and nivalenol by an in vitro gastrointestinal model, and the binding efficacy of activated carbon and other adsorbent materials. Food Chem. Toxicol. 2004, 42, 817-824.
36. Yee, S. In vitro permeability across Caco-2 cells (colonic) can predict in vivo (small intestinal) absorption in man-Fact or myth. Pharm. Res. 1997, 14, 763-766.
37. Awad, W.A.; Aschenbach, J.R.; Setyabudi, F.M.; Razzazi-Fazeli, E.; Böhm, J.; Zentek, J. In vitro effects of deoxynivalenol on small intestinal D-glucose uptake and absorption of deoxynivalenol across the isolated jejunal epithelium of laying hens. Poult. Sci. 2007, 86, 15-20.
38. Maresca, M.; Mahfoud, R.; Pfohl-Leszkowicz, A.; Fantini, J. The mycotoxin ochratoxin A alters intestinal barrier and absorption functions but has no effect on chloride secretion. Toxicol. Appl. Pharmacol. 2001, 176, 54-63.
39. Maresca, M.; Mahfoud, R.; Garmy, N.; Fantini, J. The mycotoxin deoxynivalenol affects nutrient absorption in human intestinal epithelial cells. J. Nutr. 2002, 132, 2723-2731.
40. Maresca, M.; Yahi, N.; Younès-Sakr, L.; Boyron, M.; Caporiccio, B.; Fantini, J. Both direct and indirect effects account for the pro-inflammatory activity of enteropathogenic mycotoxins on the human intestinal epithelium: Stimulation of interleukin-8 secretion, potentiation of interleukin-1beta effect and increase in the transepithelial passage of commensal bacteria. Toxicol. Appl. Pharmacol. 2008, 228, 84-92.
41. Dean, P.; Maresca, M.; Schüller, S.; Phillips, A.D.; Kenny, B. Potent diarrheagenic mechanism mediated by the cooperative action of three enteropathogenic Escherichia coli-injected effector proteins. Proc. Natl. Acad. Sci. USA 2005, 103, 1876-1881.
42. Guttman, J.A.; Finlay, B.B. Tight junctions as targets of infectious agents. Biochim. Biophys. Acta 2009, 1788, 832-841.
43. Schulzke, J.D.; Günzel, D.; John, L.J.; Fromm, M. Perspectives on tight junction research. Ann. N.Y. Acad. Sci. 2012, 1257, 1-19.
44. Takahashi, A.; Kondoh, M.; Suzuki, H.; Watari, A.; Yagi, K. Pathological changes in tight junctions and potential applications into therapies. Drug Discov. Today 2012, 17, 727-732.
45. Worrell, N.R.; Mallett, A.K.; Cook, W.M.; Baldwin, N.C.; Shepherd, M.J. The role of gut micro-organisms in the metabolism of deoxynivalenol administered to rats. Xenobiotica 1989, 19, 25-32.
46. Prelusky, D.B.; Veira, D.M.; Trenholm, H.L. Plasma pharmacokinetics of the mycotoxin deoxynivalenol following oral and intravenous administration to sheep. J. Environ. Sci. Health B 1985, 20, 603-624.
47. Prelusky, D.B.; Veira, D.M.; Trenholm, H.L.; Hartin, K.E. Excretion profiles of the mycotoxin deoxynivalenol, following oral and intravenous administration to sheep. Fundam. Appl. Toxicol. 1986, 6, 356-363.
48. Osselaere, A.; Devreese, M.; Goossens, J.; Vandenbroucke, V.; de Baere, S.; de Backer, P.; Croubels, S. Toxicokinetic study and absolute oral bioavailability of deoxynivalenol, T-2 toxin and zearalenone in broiler chickens. Food Chem. Toxicol. 2013, 51, 350-355.
49. Dnäicke, S.; Matthäus, K.; Lebzien, P.; Valenta, H.; Stemme, K.; Ueberschär, K.H.; Razzazi-Fazeli, E.; Böhm, J.; Flachowsky, G. Effects of Fusarium toxin-contaminated wheat grain on nutrient turnover, microbial protein synthesis and metabolism of deoxynivalenol and zearalenone in the rumen of dairy cows. J. Anim. Physiol. Anim. Nutr. 2005, 89, 303-315.
50. Prelusky, D.B.; Trenholm, H.L.; Lawrence, G.A.; Scott, P.M. Nontransmission of deoxynivalenol (vomitoxin) to milk following oral administration to dairy cows. J. Environ. Sci. Health B 1984, 19, 593-609.
51. Eriksen, G.S.; Pettersson, H.; Johnsen, K.; Lindberg, J.E. Transformation of trichothecenes in ileal digesta and faeces from pigs. Arch. Tierernahr. 2002, 56, 263-274.
52. Eriksen, G.S.; Pettersson, H.; Lindberg, J.E. Absorption, metabolism and excretion of 3-acetyl DON in pigs. Arch. Tierernahr. 2003, 57, 335-345.
53. Gratz, S.W.; Duncan, G.; Richardson, A.J. Human fecal microbiota metabolize deoxynivalenol and deoxynivalenol-3-glucoside and may be responsible for urinary de-epoxy deoxynivalenol. Appl. Environ. Microbiol. 2013, 79, 1821-1825.
54. Hedman, R.; Pettersson, H. Transformation of nivalenol by gastrointestinal microbes. Arch. Tierernahr. 1997, 50, 321-329.
55. Sato, I.; Ito, M.; Ishizaka, M.; Ikunaga, Y.; Sato, Y.; Yoshida, S.; Koitabashi, M.; Tsushima, S. Thirteen novel deoxynivalenol-degrading bacteria are classified within two genera with distinct degradation mechanisms. FEMS Microbiol. Lett. 2012, 327, 110-117.
56. Islam, R.; Zhou, T.; Young, J.C.; Goodwin, P.H.; Pauls, K.P. Aerobic and anaerobic de-epoxydation of mycotoxin deoxynivalenol by bacteria originating from agricultural soil. World J. Microbiol. Biotechnol. 2012, 28, 7-13.
57. Udell, M.N.; Dewick, P.M. Metabolic conversions of trichothecene mycotoxins: De-esterification reactions using cell-free extracts of Fusarium. Z. Naturforsch. C 1989, 44, 660-668.
58. Jaeger, K.E.; Reetz, M.T. Microbial lipases form versatile tools for biotechnology. Trends Biotechnol. 1998, 16, 396-403.
59. Hänninen, O.; Lindström-Seppä, P.; Pelkonen, K. Role of gut in xenobiotic metabolism. Arch. Toxicol. 1987, 60, 34-36.
60. Pinton, P.; Tsybulskyy, D.; Lucioli, J.; Laffitte, J.; Callu, P.; Lyazhri, F.; Grosjean, F.; Bracarense, A.P.; Kolf-Clauw, M.; Oswald, I.P. Toxicity of deoxynivalenol and its acetylated derivatives on the intestine: Differential effects on morphology, barrier function, tight junction proteins, and mitogen-activated protein kinases. Toxicol. Sci. 2012, 130, 180-190.
61. Wu, X.; Murphy, P.; Cunnick, J.; Hendrich, S. Synthesis and characterization of deoxynivalenol glucuronide: Its comparative immunotoxicity with deoxynivalenol. Food Chem. Toxicol. 2007, 45, 1846-1855.
62. Poppenberger, B.; Berthiller, F.; Lucyshyn, D.; Sieberer, T.; Schuhmacher, R.; Krska, R.; Kuchler, K.; Glössl, J.; Luschnig, C.; Adam, G. Detoxification of the Fusarium mycotoxin deoxynivalenol by a UDP-glucosyltransferase from Arabidopsis thaliana. J. Biol. Chem. 2003, 278, 47905-47914.
63. Dall'erta, A.; Cirlini, M.; Dall'asta, M.; del Rio, D.; Galaverna, G.; Dall'asta, C. Masked mycotoxins are efficiently hydrolyzed by human colonic microbiota releasing their aglycones. Chem. Res. Toxicol. 2013, 26, 305-312.
64. Nagl, V.; Schwartz, H.; Krska, R.; Moll, W.D.; Knasmüller, S.; Ritzmann, M.; Adam, G.; Berthiller, F. Metabolism of the masked mycotoxin deoxynivalenol-3-glucoside in rats. Toxicol. Lett. 2012, 213, 367-373.
65. CÔté, L.M.; Buck, W.; Jeffery, E. Lack of hepatic microsomal metabolism of deoxynivalenol and its metabolite, DOM-1. Food Chem. Toxicol. 1987, 25, 291-295.
66. Maul, R.; Warth, B.; Kant, J.S.; Schebb, N.H.; Krska, R.; Koch, M.; Sulyok, M. Investigation of the hepatic glucuronidation pattern of the Fusarium mycotoxin deoxynivalenol in various species. Chem. Res. Toxicol. 2012, 25, 2715-2717.
67. Uhlig, S.; Ivanova, L.; Fæste, C.K. Enzyme-assisted synthesis and structural characterization of the 3-, 8- and 15-glucuronides of deoxynivalenol. J. Agric. Food Chem. 2013, 61, 2006-2012.
68. Turner, P.C.; Hopton, R.P.; White, K.L.; Fisher, J.; Cade, J.E.; Wild, C.P. Assessment of deoxynivalenol metabolite profiles in UK adults. Food Chem. Toxicol. 2011, 49, 132-135.
69. Warth, B.; Sulyok, M.; Fruhmann, P.; Berthiller, F.; Schuhmacher, R.; Hametner, C.; Adam, G.; Fröhlich, J.; Krska, R. Assessment of human deoxynivalenol exposure using an LC-MS/MS based biomarker method. Toxicol. Lett. 2012, 211, 85-90.
70. Chu, F.S. Interaction of ochratoxin A with bovine serum albumin. Arch. Biochem. Biophys. 1971, 147, 359-366.
71. Hagelberg, S.; Hult, K.; Fuchs, R. Toxicokinetics of ochratoxin A in several species and its plasma-binding properties. J. Appl. Toxicol. 1989, 9, 91-96.
72. Li, Y.; Wang, H.; Jia, B.; Liu, C.; Liu, K.; Qi, Y.; Hu, Z. Study of the interaction of deoxynivalenol with human serum albumin by spectroscopic technique and molecular modelling. Food Addit. Contam. Part A 2013, 30, 356-364.
73. Nico, B.; Ribatti, D. Morphofunctional aspects of the blood-brain barrier. Curr. Drug Metab. 2012, 13, 50-60.
74. Prelusky, D.B.; Hartin, K.E.; Trenholm, H.L. Distribution of deoxynivalenol in cerebral spinal fluid following administration to swine and sheep. J. Environ. Sci. Health B 1990, 25, 395-413.
75. Pestka, J.J.; Islam, Z.; Amuzie, C.J. Immunochemical assessment of deoxynivalenol tissue distribution following oral exposure in the mouse. Toxicol. Lett. 2008, 178, 83-87.
76. Diaz, G.J.; Boermans, H.J. Fumonisin toxicosis in domestic animals: A review. Vet. Hum. Toxicol. 1994, 36, 548-555.
77. Foreman, J.H.; Constable, P.D.; Waggoner, A.L.; Levy, M.; Eppley, R.M.; Smith, G.W.; Tumbleson, M.E.; Haschek, W.M. Neurologic abnormalities and cerebrospinal fluid changes in horses administered fumonisin B1 intravenously. J. Vet. Intern. Med. 2004, 18, 223-230.
78. Osuchowski, M.F.; He, Q.; Sharma, R.P. Endotoxin exposure alters brain and liver effects of fumonisin B1 in BALB/c mice: Implication of blood brain barrier. Food Chem. Toxicol. 2005, 43, 1389-1397.
79. Swenberg, J.A.; Lu, K.; Moeller, B.C.; Gao, L.; Upton, P.B.; Nakamura, J.; Starr, T.B. Endogenous versus exogenous DNA adducts: Their role in carcinogenesis, epidemiology, and risk assessment. Toxicol. Sci. 2011, 120, S130-S145.
80. Bedard, L.L.; Massey, T.E. Aflatoxin B1-induced DNA damage and its repair. Cancer Lett. 2006, 241, 174-183.
81. Sabbioni, G.; Skipper, P.L.; Büchi, G.; Tannenbaum, S.R. Isolation and characterization of the major serum albumin adduct formed by aflatoxin B1 in vivo in rats. Carcinogenesis. 1987, 8, 819-824.
82. He, K.; Zhou, H.R.; Pestka, J.J. Mechanisms for ribotoxin-induced ribosomal RNA cleavage. Toxicol. Appl. Pharmacol. 2012, 265, 10-18.
83. He, K.; Zhou, H.R.; Pestka, J.J. Targets and intracellular signaling mechanisms for deoxynivalenol-induced ribosomal RNA cleavage. Toxicol. Sci. 2012, 127, 382-390.
84. Yang, G.H.; Li, S.; Pestka, J.J. Down-regulation of the endoplasmic reticulum chaperone GRP78/BiP by vomitoxin (Deoxynivalenol). Toxicol. Appl. Pharmacol. 2000, 162, 207-217.
85. Yang, H.; Park, S.H.; Choi, H.J.; Moon, Y. Epithelial cell survival by activating transcription factor 3 (ATF3) in response to chemical ribosome-inactivating stress. Biochem. Pharmacol. 2009, 77, 1105-1115.
86. Moon, Y.; Yang, H.; Lee, S.H. Modulation of early growth response gene 1 and interleukin-8 expression by ribotoxin deoxynivalenol (vomitoxin) via ERK1/2 in human epithelial intestine 407 cells. Biochem. Biophys. Res. Commun. 2007, 362, 256-262.
87. Ansari, K.I.; Hussain, I.; Das, H.K.; Mandal, S.S. Overexpression of human histone ethylase MLL1 upon exposure to a food contaminant mycotoxin, deoxynivalenol. FEBS J. 2009, 276, 3299-3307.
88. Choi, H.J.; Yang, H.; Park, S.H.; Moon, Y. HuR/ELAVL1 RNA binding protein modulates interleukin-8 induction by muco-active ribotoxin deoxynivalenol. Toxicol. Appl. Pharmacol. 2009, 240, 46-54.
89. Park, S.H.; Choi, H.J.; Yang, H.; Do, K.H.; Kim, J.; Moon, Y. Repression of peroxisome proliferator-activated receptor gamma by mucosal ribotoxic insult-activated CAAT/enhancer-binding protein homologous protein. J. Immunol. 2010, 185, 5522-5530.
90. Pan, X.; Whitten, D.A.; Wu, M.; Chan, C.; Wilkerson, C.G.; Pestka, J.J. Global protein phosphorylation dynamics during deoxynivalenol-induced ribotoxic stress response in the macrophage. Toxicol. Appl. Pharmacol. 2013, 268, 201-211.
91. Forsell, J.H.; Pestka, J.J. Relation of 8-ketotrichothecene and zearalenone analog structure to inhibition of mitogen-induced human lymphocyte blastogenesis. Appl. Environ. Microbiol. 1985, 50, 1304-1307.
92. Bondy, G.S.; McCormick, S.P.; Beremand, M.N.; Pestka, J.J. Murine lymphocyte proliferation impaired by substituted neosolaniols and calonectrins-Fusarium metabolites associated with trichothecene biosynthesis. Toxicon 1991, 29, 1107-1113.
93. Berek, L.; Petri, I.B.; Mesterházy, A.; Téren, J.; Molnár, J. Effects of mycotoxins on human immune functions in vitro. Toxicol. in Vitro 2001, 15, 25-30.
94. Forsell, J.H.; Jensen, R.; Tai, J.H.; Witt, M.; Lin, W.S.; Pestka, J.J. Comparison of acute toxicities of deoxynivalenol (vomitoxin) and 15-acetyldeoxynivalenol in the B6C3F1 mouse. Food Chem. Toxicol. 1987, 25, 155-162.
95. Bouhet, S.; Oswald, I.P. The intestine as a possible target for fumonisin toxicity. Mol. Nutr. Food Res. 2007, 51, 925-931.
96. Instanes, C.; Hetland, G. Deoxynivalenol (DON) is toxic to human colonic, lung and monocytic cell lines, but does not increase the IgE response in a mouse model for allergy. Toxicology 2004, 204, 13-21.
97. Diesing, A.K.; Nossol, C.; Panther, P.; Walk, N.; Post, A.; Kluess, J.; Kreutzmann, P.; Dänicke, S.; Rothkötter, H.J.; Kahlert, S. Mycotoxin deoxynivalenol (DON) mediates biphasic cellular response in intestinal porcine epithelial cell lines IPEC-1 and IPEC-J2. Toxicol. Lett. 2011, 200, 8-18.
98. Diesing, A.K.; Nossol, C.; Dänicke, S.; Walk, N.; Post, A.; Kahlert, S.; Rothkötter, H.J.; Kluess, J. Vulnerability of polarised intestinal porcine epithelial cells to mycotoxin deoxynivalenol depends on the route of application. PLoS One 2011, 6, e17472.
99. Vandenbroucke, V.; Croubels, S.; Martel, A.; Verbrugghe, E.; Goossens, J.; van Deun, K.; Boyen, F.; Thompson, A.; Shearer, N.; de Backer, P.; et al. The mycotoxin deoxynivalenol potentiates intestinal inflammation by Salmonella typhimurium in porcine ileal loops. PLoS One 2011, 6, e23871.
100. Bianco, G.; Fontanella, B.; Severino, L.; Quaroni, A.; Autore, G.; Marzocco, S. Nivalenol and deoxynivalenol affect rat intestinal epithelial cells: A concentration related study. PLoS One 2012, 7, e52051.
101. Diesing, A.K.; Nossol, C.; Ponsuksili, S.; Wimmers, K.; Kluess, J.; Walk, N.; Post, A.; Rothkötter, H.J.; Kahlert, S. Gene regulation of intestinal porcine epithelial cells IPEC-J2 is dependent on the site of deoxynivalenol toxicological action. PLoS One 2012, 7, e34136.
102. Awad, W.A.; Razzazi-Fazeli, E.; Böhm, J.; Zentek, J. Influence of deoxynivalenol on the D-glucose transport across the isolated epithelium of different intestinal segments of laying hens. J. Anim. Physiol. Anim. Nutr. 2007, 91, 175-180.
103. Awad, W.A.; Razzazi-Fazeli, E.; B̈hm, J.; Zentek, J. Effects of B-trichothecenes on luminal glucose transport across the isolated jejunal epithelium of broiler chickens. J. Anim. Physiol. Anim. Nutr. 2008, 92, 225-230.
104. +
105. Meinild, A.; Klaerke, D.A.; Loo, D.D.; Wright, E.M.; Zeuthen, T. The human Na -glucose cotransporter is a molecular water pump. J. Physiol. 1998, 508, 15-21.
106. Amador, P.; García-Herrera, J.; Marca, M.C.; de La Osada, J.; Acín, S.; Navarro, M.A.; Salvador, M.T.; Lostao, M.P.; Rodríguez-Yoldi, M.J. Inhibitory effect of TNF-alpha on the intestinal absorption of galactose. J. Cell. Biochem. 2007, 101, 99-111.
107. Amador, P.; Marca, M.C.; García-Herrera, J.; Lostao, M.P.; Guillén, N.; de La Osada, J.; Rodríguez-Yoldi, M.J. Lipopolysaccharide induces inhibition of galactose intestinal transport in rabbits in vitro. Cell. Physiol. Biochem. 2008, 22, 715-724.
108. Pinton, P.; Nougayrède, J.P.; del Rio, J.C.; Moreno, C.; Marin, D.E.; Ferrier, L.; Bracarense, A.P.; Kolf-Clauw, M.; Oswald, I.P. The food contaminant deoxynivalenol, decreases intestinal barrier permeability and reduces claudin expression. Toxicol. Appl. Pharmacol. 2009, 237, 41-48.
109. Vandenbroucke, V.; Croubels, S.; Verbrugghe, E.; Boyen, F.; de Backer, P.; Ducatelle, R.; Rychlik, I.; Haesebrouck, F.; Pasmans, F. The mycotoxin deoxynivalenol promotes uptake of Salmonella typhimurium in porcine macrophages, associated with ERK1/2 induced cytoskeleton reorganization. Vet. Res. 2009, 40, 64.
110. Obremski, K.; Zielonka, L.; Gajecka, M.; Jakimiuk, E.; Bakuła, T.; Baranowski, M.; Gajecki, M. Histological estimation of the small intestine wall after administration of feed containing deoxynivalenol, T-2 toxin and zearalenone in the pig. Pol. J. Vet. Sci. 2008, 11, 339-345.
111. Bracarense, A.P.; Lucioli, J.; Grenier, B.; Drociunas Pacheco, G.; Moll, W.D.; Schatzmayr, G.; Oswald, I.P. Chronic ingestion of deoxynivalenol and fumonisin, alone or in interaction, induces morphological and immunological changes in the intestine of piglets. Br. J. Nutr. 2012, 107, 1776-1786.
112. Wach, Y.J.; Valat, C.; Postollec, G.; Bougeard, S.; Burel, C.; Oswald, I.P.; Fravalo, P. Impact of deoxynivalenol on the intestinal microflora of pigs. Int. J. Mol. Sci. 2009, 10, 1-17.
113. Krishnaswamy, R.; Devaraj, S.N.; Padma, V.V. Lutein protects HT-29 cells against Deoxynivalenol-induced oxidative stress and apoptosis: Prevention of NF-kappaB nuclear localization and down regulation of NF-kappaB and Cyclo-Oxygenase-2 expression. Free Radic. Biol. Med. 2010, 49, 50-60.
114. Van de Walle, J.; During, A.; Piront, N.; Toussaint, O.; Schneider, Y.J.; Larondelle, Y. Physio-pathological parameters affect the activation of inflammatory pathways by deoxynivalenol in Caco-2 cells. Toxicol. in Vitro 2010, 24, 1890-1898.
115. Wan, M.L.; Woo, C.S.; Allen, K.J.; Turner, P.C.; El-Nezami, H. Modulation of porcine β-defensins 1 and 2 upon individual and combined Fusarium toxin exposure in a swine jejunal epithelial cell line. Appl. Environ. Microbiol. 2013, 79, 2225-2232.
116. Van de Walle, J.; Romier, B.; Larondelle, Y.; Schneider, Y.J. Influence of deoxynivalenol on NF-kappaB activation and IL-8 secretion in human intestinal Caco-2 cells. Toxicol. Lett. 2008, 177, 205-214.
117. Cano, P.M.; Seeboth, J.; Meurens, F.; Cognie, J.; Abrami, R.; Oswald, I.P.; Guzylack-Piriou, L. Deoxynivalenol as a new factor in the persistence of intestinal inflammatory diseases: An emerging hypothesis through possible modulation of Th17-mediated response. PLoS One 2013, 8, e53647.
118. Hara-Kudo, Y.; Sugita-Konishi, Y.; Kasuga, F.; Kumagai, S. Effects of deoxynivalenol on Salmonella enteritidis infection. Mycotoxins 1996, 42, 51-55.
119. Li, M.; Cuff, C.F.; Pestka, J. Modulation of murine host response to enteric reovirus infection by the trichothecene deoxynivalenol. Toxicol. Sci. 2005, 87, 134-145.
120. Atkinson, H.A.; Miller, K. Inhibitory effect of deoxynivalenol, 3-acetyldeoxynivalenol and zearalenone on induction of rat and human lymphocyte proliferation. Toxicol. Lett. 1984, 23, 215-221.
121. Miller, K.; Atkinson, H.A. The in vitro effects of trichothecenes on the immune system. Food Chem. Toxicol. 1986, 24, 545-549.
122. Virelizier, J.L.; Arenzana-Seisdedos, F. Immunological functions of macrophages and their regulation by interferons. Med. Biol. 1985, 63, 149-159.
123. Sugita-Konishi, Y.; Pestka, J.J. Differential upregulation of TNF-alpha, IL-6, and IL-8 production by deoxynivalenol (vomitoxin) and other 8-ketotrichothecenes in a human macrophage model. J. Toxicol. Environ. Health A 2001, 64, 619-636.
124. Döll, S.; Schrickx, J.A.; Dänicke, S.; Fink-Gremmels, J. Deoxynivalenol-induced cytotoxicity, cytokines and related genes in unstimulated or lipopolysaccharide stimulated primary porcine macrophages. Toxicol. Lett. 2009, 184, 97-106.
125. Sugiyama, K.; Muroi, M.; Tanamoto, K.; Nishijima, M.; Sugita-Konishi, Y. Deoxynivalenol and nivalenol inhibit lipopolysaccharide-induced nitric oxide production by mouse macrophage cells. Toxicol. Lett. 2010, 192, 150-154.
126. Ayral, A.M.; Dubech, N.; le Bars, J.; Escoula, L. In vitro effect of diacetoxyscirpenol and deoxynivalenol on microbicidal activity of murine peritoneal macrophages. Mycopathologia 1992, 120, 121-127.
127. Waché, Y.J.; Hbabi-Haddioui, L.; Guzylack-Piriou, L.; Belkhelfa, H.; Roques, C.; Oswald, I.P. The mycotoxin deoxynivalenol inhibits the cell surface expression of activation markers in human macrophages. Toxicology 2009, 262, 239-244.
128. Li, M.; Harkema, J.R.; Cuff, C.F.; Pestka, J.J. Deoxynivalenol exacerbates viral bronchopneumonia induced by respiratory reovirus infection. Toxicol. Sci. 2007, 95, 412-426.
129. Wang, X.; Liu, Q.; Ihsan, A.; Huang, L.; Dai, M.; Hao, H.; Cheng, G.; Liu, Z.; Wang, Y.; Yuan, Z. JAK/STAT pathway plays a critical role in the proinflammatory gene expression and apoptosis of RAW264.7 cells induced by trichothecenes as DON and T-2 toxin. Toxicol. Sci. 2012, 127, 412-424.
130. Yan, D.; Zhou, H.R.; Brooks, K.H.; Pestka, J.J. Potential role for IL-5 and IL-6 in enhanced IgA secretion by Peyer's patch cells isolated from mice acutely exposed to vomitoxin. Toxicology 1997, 122, 145-158.
131. Yan, D.; Zhou, H.R.; Brooks, K.H.; Pestka, J.J. Role of macrophages in elevated IgA and IL-6 production by Peyer's patch cultures following acute oral vomitoxin exposure. Toxicol. Appl. Pharmacol. 1998, 148, 261-273.
132. Vivier, E.; Tomasello, E.; Baratin, M.; Walzer, T.; Ugolini, S. Functions of natural killer cells. Nat. Immunol. 2008, 9, 503-510.
133. Pinton, P.; Accensi, F.; Beauchamp, E.; Cossalter, A.M.; Callu, P.; Grosjean, F.; Oswald, I.P. Ingestion of deoxynivalenol (DON) contaminated feed alters the pig vaccinal immune responses. Toxicol. Lett. 2008, 177, 215-222.
134. Oswald, I.P.; Marin, D.E.; Bouhet, S.; Pinton, P.; Taranu, I.; Accensi, F. Immunotoxicological risk of mycotoxins for domestic animals. Food Addit. Contam. 2005, 22, 354-360.
135. Taranu, I.; Marina, D.E.; Burlacu, R.; Pinton, P.; Damian, V.; Oswald, I.P. Comparative aspects of in vitro proliferation of human and porcine lymphocytes exposed to mycotoxins. Arch. Anim. Nutr. 2010, 64, 383-393.
136. Meky, F.A.; Hardie, L.J.; Evans, S.W.; Wild, C.P. Deoxynivalenol-induced immunomodulation of human lymphocyte proliferation and cytokine production. Food Chem. Toxicol. 2001, 39, 827-836.
137. Pestka, J.J. Deoxynivalenol-induced IgA production and IgA nephropathy-aberrant mucosal immune response with systemic repercussions. Toxicol. Lett. 2003, 140-141, 287-295.
138. Rasooly, L.; Pestka, J.J. Vomitoxin-induced dysregulation of serum IgA, IgM and IgG reactive with gut bacterial and self antigens. Food Chem. Toxicol. 1992, 30, 499-504.
139. Dänicke, S.; Hegewald, A.K.; Kahlert, S.; Kluess, J.; Rothk̈tter, H.J.; Breves, G.; Döll, S. Studies on the toxicity of deoxynivalenol (DON), sodium metabisulfite, DON-sulfonate (DONS) and de-epoxy-DON for porcine peripheral blood mononuclear cells and the Intestinal Porcine Epithelial Cell lines IPEC-1 and IPEC-J2, and on effects of DON and DONS on piglets. Food Chem. Toxicol. 2010, 48, 2154-2162.
140. Ndossi, D.G.; Frizzell, C.; Tremoen, N.H.; Fæste, C.K.; Verhaegen, S.; Dahl, E.; Eriksen, G.S.; SØrlie, M.; Connolly, L.; Ropstad, E. An in vitro investigation of endocrine disrupting effects of trichothecenes deoxynivalenol (DON), T-2 and HT-2 toxins. Toxicol. Lett. 2012, 214, 268-278.
141. Medvedova, M.; Kolesarova, A.; Capcarova, M.; Labuda, R.; Sirotkin, A.V.; Kovacik, J.; Bulla, J. The effect of deoxynivalenol on the secretion activity, proliferation and apoptosis of porcine ovarian granulosa cells in vitro. J. Environ. Sci. Health B 2011, 46, 213-219.
142. Kolesarova, A.; Capcarova, M.; Maruniakova, N.; Lukac, N.; Ciereszko, R.E.; Sirotkin, A.V. Resveratrol inhibits reproductive toxicity induced by deoxynivalenol. J. Environ. Sci. Health A 2012, 47, 1329-1334.
143. Amuzie, C.J.; Pestka, J.J. Suppression of insulin-like growth factor acid-labile subunit expression-A novel mechanism for deoxynivalenol-induced growth retardation. Toxicol. Sci. 2010, 113, 412-421.
144. Voss, K.A. A new perspective on deoxynivalenol and growth suppression. Toxicol. Sci. 2010, 113, 281-283.
145. Szkudelska, K.; Szkudelski, T.; Nogowski, L. Short-time deoxynivalenol treatment induces metabolic disturbances in the rat. Toxicol. Lett. 2002, 136, 25-31.
146. Flannery, B.M.; Clark, E.S.; Pestka, J.J. Anorexia induction by the trichothecene deoxynivalenol (vomitoxin) is mediated by the release of the gut satiety hormone peptide YY. Toxicol. Sci. 2012, 130, 289-297.
147. Razafimanjato, H.; Benzaria, A.; Taïeb, N.; Guo, X.J.; Vidal, N.; di Scala, C.; Varini, K.; Maresca, M. The ribotoxin deoxynivalenol affects the viability and functions of glial cells. Glia 2011, 59, 1672-1683.
148. Razafimanjato, H.; Garmy, N.; Guo, X.J.; Varini, K.; di Scala, C.; di Pasquale, E.; Taïeb, N.; Maresca, M. The food-associated fungal neurotoxin ochratoxin A inhibits the absorption of glutamate by astrocytes through a decrease in cell surface expression of the excitatory amino-acid transporters GLAST and GLT-1. Neurotoxicology 2010, 31, 475-484.
149. Wang, D.D.; Bordey, A. The astrocyte odyssey. Prog. Neurobiol. 2008, 86, 342-367.
150. Varini, K.; Benzaria, A.; Taïeb, N.; di Scala, C.; Azmi, A.; Graoudi, S.; Maresca, M. Mislocalization of the exitatory amino-acid transporters (EAATs) in human astrocytoma and non-astrocytoma cancer cells: Effect of the cell confluence. J. Biomed. Sci. 2012, 19, 10.
151. Ren, K.; Dubner, R. Neuron-glia crosstalk gets serious: Role in pain hypersensitivity. Curr. Opin. Anaesthesiol. 2008, 21, 570-579.
152. Gibbs, M.E.; Hutchinson, D.; Hertz, L. Astrocytic involvement in learning and memory consolidation. Neurosci. Biobehav. Rev. 2008, 32, 927-944.
153. Bonnet, M.S.; Roux, J.; Mounien, L.; Dallaporta, M.; Troadec, J.D. Advances in deoxynivalenol toxicity mechanisms: The brain as a target. Toxins 2012, 4, 1120-1138.
154. Fitzpatrick, D.W.; Boyd, K.E.; Wilson, L.M.; Wilson, J.R. Effect of the trichothecene deoxynivalenol on brain biogenic monoamines concentrations in rats and chickens. J. Environ. Sci. Health B 1988, 23, 159-170.
155. Prelusky, D.B.; Yeung, J.M.; Thompson, B.K.; Trenholm, H.L. Effect of deoxynivalenol on neurotransmitters in discrete regions of swine brain. Arch. Environ. Contam. Toxicol. 1992, 22, 36-40.
156. Prelusky, D.B. A study on the effect of deoxynivalenol on serotonin receptor binding in pig brain membranes. J. Environ. Sci. Health B 1996, 31, 1103-1117.
157. Ossenkopp, K.P.; Hirst, M.; Rapley, W.A. Deoxynivalenol (vomitoxin)-induced conditioned taste aversions in rats are mediated by the chemosensitive area postrema. Pharmacol. Biochem. Behav. 1994, 47, 363-367.
158. Girardet, C.; Bonnet, M.S.; Jdir, R.; Sadoud, M.; Thirion, S.; Tardivel, C.; Roux, J.; Lebrun, B.; Wanaverbecq, N.; Mounien, L.; et al. The food-contaminant deoxynivalenol modifies eating by targeting anorexigenic neurocircuitry. PLoS One 2011, 6, e26134.
159. Girardet, C.; Bonnet, M.S.; Jdir, R.; Sadoud, M.; Thirion, S.; Tardivel, C.; Roux, J.; Lebrun, B.; Mounien, L.; Trouslard, J.; et al. Central inflammation and sickness-like behavior induced by the food contaminant deoxynivalenol: A PGE2-independent mechanism. Toxicol. Sci. 2011, 124, 179-191.
160. Gaigé, S.; Bonnet, M.S.; Tardivel, C.; Pinton, P.; Trouslard, J.; Jean, A.; Guzylack, L.; Troadec, J.D.; Dallaporta, M. c-Fos immunoreactivity in the pig brain following deoxynivalenol intoxication: Focus on NUCB2/nesfatin-1 expressing neurons. Neurotoxicology 2013, 34, 135-149.
161. Langhans, W. Signals generating anorexia during acute illness. Proc. Nutr. Soc. 2007, 66, 321-330.
162. Pestka, J.J.; Zhou, H.R. Effects of tumor necrosis factor type 1 and 2 receptor deficiencies on anorexia, growth and IgA dysregulation in mice exposed to the trichothecene vomitoxin. Food Chem. Toxicol. 2002, 40, 1623-1631.
163. Dallaporta, M.; Bonnet, M.S.; Horner, K.; Trouslard, J.; Jean, A.; Troadec, J.D. Glial cells of the nucleus tractus solitarius as partners of the dorsal hindbrain regulation of energy balance: A proposal for a working hypothesis. Brain Res. 2010, 1350, 35-42.
164. Wu, W.; Flannery, B.M.; Sugita-Konishi, Y.; Watanabe, M.; Zhang, H.; Pestka, J.J. Comparison of murine anorectic responses to the 8-ketotrichothecenes 3-acetyldeoxynivalenol, 15-acetyldeoxynivalenol, fusarenon X and nivalenol. Food Chem. Toxicol. 2012, 50, 2056-2061.
165. Turner, P.C.; Hopton, R.P.; Lecluse, Y.; White, K.L.; Fisher, J.; Lebailly, P. Determinants of urinary deoxynivalenol and de-epoxy deoxynivalenol in male farmers from Normandy, France. J. Agric. Food Chem. 2010, 58, 5206-5212.
166. Turner, P.C.; Flannery, B.; Isitt, C.; Ali, M.; Pestka, J. The role of biomarkers in evaluating human health concerns from fungal contaminants in food. Nutr. Res. Rev. 2012, 25, 162-179.
167. Warth, B.; Sulyok, M.; Fruhmann, P.; Mikula, H.; Berthiller, F.; Schuhmacher, R.; Hametner, C.; Abia, W.A.; Adam, G.; Fröhlich, J.; et al. Development and validation of a rapid multi-biomarker liquid chromatography/tandem mass spectrometry method to assess human exposure to mycotoxins. Rapid Commun. Mass Spectrom. 2012, 26, 1533-1540.
168. Muri, S.D.; van der Voet, H.; Boon, P.E.; van Klaveren, J.D.; Brüschweiler, B.J. Comparison of human health risks resulting from exposure to fungicides and mycotoxins via food. Food Chem. Toxicol. 2009, 47, 2963-2974.
169. Mattsson, J.L. Mixtures in the real world: The importance of plant self-defense toxicants, mycotoxins, and the human diet. Toxicol. Appl. Pharmacol. 2007, 223, 125-132.
170. Wild, C.P.; Gong, Y.Y. Mycotoxins and human disease: A largely ignored global health issue. Carcinogenesis 2010, 31, 71-82.
171. Kluger, B.; Bueschl, C.; Lemmens, M.; Berthiller, F.; Häubl, G.; Jaunecker, G.; Adam, G.; Krska, R.; Schuhmacher, R. Stable isotopic labelling-assisted untargeted metabolic profiling reveals novel conjugates of the mycotoxin deoxynivalenol in wheat. Anal. Bioanal. Chem. 2012, doi:10.1007/s00216-012-6483-8
172. Zachariasova, M.; Vaclavikova, M.; Lacina, O.; Vaclavik, L.; Hajslova, J. Deoxynivalenol oligoglycosides: New "masked" fusarium toxins occurring in malt, beer, and breadstuff. J. Agric. Food Chem. 2012, 60, 9280-9291.